Newstral
Article
Haaretz on 2016-08-03 17:30
Israel's Teva Buys Top Competitor Allergan's Generic Drug Distributor
Related news
- CIsrael's Teva buys Allergan generic drug company for $40.5Bcontracostatimes.com
- Israel's Teva Pharmaceutical to buy Allergan's generic pharmaceuticals business for $40.5BTimesDaily.com
- Israel's Teva buys Allergen generic drug company for $40.5Bmcall.com
- Teva drops bid for Mylan, buys Allergan's generic drug unitbizjournals.com
- Allergan sells generic drug company to Israel's Teva for $40.5 billionLA Times
- Teva launches eighth generic ADHD drugbizjournals.com
- Teva launches generic high blood pressure medicinebizjournals.com
- Teva drops bid for Mylan, buys Allergan generic drug company for $40.5 billionpost-gazette.com
- Teva makes unsolicited $40B offer for rival generic drug makerbizjournals.com
- Teva buys Allergan generic drug firm for $40.5BUSA today
- Israel’s Teva buys Allergan generic drug company for $40.5Breviewtimes.com
- Israel’s Teva buys Allergan generic drug company for $40.5 billionpressherald.com
- Philadelphia generic drug company buying competitor for $42Mbizjournals.com
- Source: Teva nears deal for Allergan's generic drugs unitThe Canadian Jewish News